| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
21,328 |
19,050 |
$1.14M |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
3,620 |
3,398 |
$195K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
3,558 |
3,317 |
$192K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
2,480 |
2,361 |
$140K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
5,086 |
4,836 |
$125K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,295 |
2,085 |
$119K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
11,288 |
10,149 |
$90K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
7,114 |
3,670 |
$73K |
| 90723 |
|
2,336 |
2,227 |
$43K |
| 90648 |
|
2,359 |
2,212 |
$42K |
| 90670 |
|
2,249 |
2,128 |
$42K |
| 87634 |
|
715 |
669 |
$33K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,454 |
2,344 |
$31K |
| 90633 |
|
1,628 |
1,550 |
$30K |
| 99381 |
|
553 |
509 |
$30K |
| 90707 |
|
1,495 |
1,354 |
$26K |
| 90716 |
|
1,493 |
1,350 |
$26K |
| 92551 |
|
6,953 |
6,064 |
$23K |
| 90680 |
|
1,233 |
1,165 |
$23K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
216 |
205 |
$18K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,132 |
972 |
$16K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
505 |
485 |
$16K |
| 90677 |
|
888 |
848 |
$16K |
| 90651 |
|
964 |
818 |
$15K |
| 90734 |
|
771 |
644 |
$12K |
| 90688 |
|
644 |
627 |
$12K |
| 90647 |
|
568 |
561 |
$11K |
| 83655 |
|
804 |
749 |
$11K |
| 90681 |
|
563 |
548 |
$10K |
| 90700 |
|
452 |
449 |
$9K |
| 90696 |
|
526 |
419 |
$8K |
| 96127 |
|
2,490 |
2,408 |
$7K |
| 85013 |
|
1,228 |
1,159 |
$3K |
| 90620 |
|
194 |
158 |
$3K |
| 90715 |
|
199 |
142 |
$3K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
154 |
76 |
$2K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
15 |
12 |
$1K |
| 90710 |
|
88 |
60 |
$1K |
| 36416 |
|
549 |
506 |
$1K |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
64 |
29 |
$974.61 |
| 87807 |
|
92 |
90 |
$913.00 |
| 90697 |
|
29 |
27 |
$514.54 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
21 |
12 |
$421.94 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
23 |
23 |
$295.90 |
| 81003 |
|
72 |
68 |
$201.00 |
| 86580 |
|
76 |
31 |
$198.00 |
| 81025 |
|
12 |
12 |
$36.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
85 |
85 |
$29.85 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
149 |
148 |
$19.00 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
98 |
98 |
$0.00 |